Director of Digital Health at IDEO
Director of Digital Health at IDEO
Principal at Flare Capital Partners
Director, Global Health and Executive Program of Aurora St Luke Medical Center, Milwaukee, WI
Vice President of North America, Foxconn Healthcare & Bioscience Business Group
President and CEO at Amarex Clinical Research
Director of Ren Shin Wellness Park
Head of Merck Accelerator
Head of the Merck Innovation Center
Deep Learning Solution Architect of NVIDIA
Managing Director of PwC Strategy&
Co-founder of IQGEN
Founder at Transplant Collective
Founder of Ferrum Health
Principal Investigator and Salk Fellow
General Partner of the Valley Fund
Superintendent of Taipei Medical University Hospital
Ph.D., Massachusetts Institute of Technology
Founder of Havital HK Holdings Limited
CEO and founder of Gauss Surgical
Founder of SimplyVital Health
Director of Head Data Acquisition at UCB Pharma
Pablo is the Director of Digital Health at IDEO. He partners with startups and global corporations alike to develop digital products and services at the intersection of health and other industries, such as mobility, retail, and education. Pablo was selected in the Forbes 30 Under 30 list in healthcare in 2016. He is also an endeavor entrepreneur and has mentored several other startups. Pablo holds a Master’s degree in Business Administration.
Dan Gebremedhin is a Principal at Flare Capital Partners where he focuses on identifying early stage companies that harness technology. Prior to joining Flare, Dan served as the Associate Medical Director at the Harvard Pilgrim Health Plan, focusing on Population Health Analytics and Value Based Purchasing. Dan is a practicing Internal Medicine Physician on the Faculty of the Massachusetts General Hospital, and has an appointment as an Instructor at Harvard Medical School. Previously, Dan spent time as an entrepreneur and operator in the Health IT Industry, cofounding and managing two separate businesses in the Electronic Health Records and Online Medical Education industries.
Dr. Bijoy Khandheria is a cardiologist in Milwaukee, Wisconsin and is affiliated with multiple hospitals in the area like Aurora St. Luke's Medical Center. He received his medical degree from Baroda Medical College and has been in practice for more than 20 years.
Charlie Alvarez is a multi-national design, manufacturing & logistics services provider for Computer, Healthcare, Communications and Consumer Electronics industries. A service company rather than a manufacturing company, Foxconn defines company products through Speed, Quality, Engineering Services, Flexibility and Monetary Cost Saving. Foxconn's M Group is the Healthcare division dedicated to bringing cutting-edge, innovative products and services to the market.
Dr. Kazempour, President & CEO of Amarex Clinical Research, has over 30 years of clinical trial experience. His experience includes working within the US FDA as a reviewer, working in the pharmaceutical industry, and representing to the US FDA all Amarex clients seeking product approval. During his more than 30 years of experience in biomedical research, Dr. Kazempour has conducted research activities with NIH, the pharmaceutical industry and also with various universities. Dr. Kazempour has worked in many therapeutic areas including vaccines, anti-infectives, anti-virals, AIDS/HIV, and cardiovascular, as well as medical devices, as his expertise and knowledge has been a key contributor in the approval of these drugs and devices.
Chrissy Wang is a passionate and fearless American Taiwanese who's transitioned from no exercise at all to being the first woman in Taiwan to complete the Big Six World Marathon Majors. She has had 15 years of healthcare management experience and in 2017, using her passion and drive for all things in her life, she's created Ren Shin Wellness Park, offering a refreshing take on long-term care. The Wellness Park has been named "the new benchmark for long-term care in Taiwan".
Born in Zimbabwe, educated in England and Germany, at home in Darmstadt. Munya Chivasa, 31, has run the whole Accelerator program from the company’s German HQ since June 2015. With a BSc in Biochemistry and Pharmacology as well as a master’s degree in Management, he is ideally qualified for the job. Munya helped conceive the Accelerator and is now responsible for its development, expansion, and smooth running. He also helps startups establish networks of external experts and investors.
Michael Gamber has worked on the development of the concept of the Innovation Center for more than three years in his role as Merck In-house Consultant before taking over the lead of the Innovation Center in 2015. With an academic background in business administration, information management, and business education he joined the In-house Consulting department of Merck in 2010. In this role, Michael worked on different projects dealing with innovation management, strategy and business process management. Prior to that Michael held different international consulting roles at PA Consulting Group, Capco, and PricewaterhouseCoopers. Michael received his diploma from the University of Mannheim in 2005.
Andrew Liu is a senior deep learning solution architect at NVIDIA, assist customers in building innovative solutions based on NVIDIA technology. His research interests are in the area of applying machine learning algorithms to real-world problems. Prior to NVIDIA, Andrew was a machine learning engineer at Foxconn. He took the lead of the analytical team, developed various kinds of predictive modeling projects centered around manufacturing processes, including defect inspection and predictive maintenance, etc. During the Ph.D. program, he has worked as a visiting scholar at Los Alamos National Laboratory's BioScience Team, working on Human and Environmental Microbiome Projects.
Brian Williams has nearly twenty years of investment, business development, and strategy expertise within the healthcare industry. As a member of PwC Strategy&’s healthcare team, Brian advises the senior executives of traditional medical device and diagnostics companies about the healthcare industry’s evolution into the “New Health Economy.” Prior to joining PwC, Brian was an executive at two healthcare companies, including one early-stage business for which he quadrupled revenues in three years, leading to the sale of the company for ten times its invested capital.
Aman is a healthcare visionary. In his professional career spanning over 8 years, he has had diverse working experience from academia, to mid-cap biotech to public-private research organization funded by all major Pharma companies and numerous healthcare based startups. Aman is currently the Founder and Managing Partner of one of Asia’s leading Health tech-focused investment and advisory firms IQGEN looking to invest in countries like Japan, Malaysia, Taiwan, Indonesia, Thailand, besides South Asia and the Middle East. He was nominated as Prime Minister’s Top 40 under 40 emerging entrepreneurs of Canada to NextFounders, and member of the Executive Club of Canada.
Yi-Min is the Head of Visual Content at Doximity. As a medical illustrator and designer, she drives the intersection of art and science for the largest HIPAA-secure medical network in the United States, with over 70% of US physicians as members. Doximity helps physicians securely connect and collaborate on patient care, referrals, research, education, and careers. Her former background as a kidney transplant researcher also led her to found Transplant Collective, an online resource assisting kidney patients in post-transplant recovery through educational videos and newsletter content.
Pelu is the Cofounder of Augmedix and Ferrum, healthcare technology startups based in San Francisco dedicated to improving patient care. He is a member of the World Economic Forum Technology Pioneers, a Fellow at the UN World Summit on Innovation, a member of the Forbes Healthcare 30 under 30, an Aspen Institute Scholar, and a Johns Hopkins CTY Distinguished Alumni. Pelu has guest lectured at UC Berkeley, UCSF, and Stanford on healthcare leadership and innovation.
Patrick Hsu is a Principal Investigator at the Salk Institute for Biological Studies, where his lab develops and applies next-generation genome engineering technologies. Recently, the Hsu lab discovered and developed novel CRISPR systems that expand the genome editing toolbox beyond DNA to RNA. Working with Feng Zhang at the Broad Institute of MIT and Harvard, he contributed to the early development of CRISPR-Cas9. At Editas Medicine, Patrick also previously led preclinical discovery projects to translate these tools for treating human genetic disorders. He has been recognized for these contributions by Forbes' 30 Under 30 and the NIH Director's Early Independence Award.
Raymond Choi is a General Partner of Valley Capital Partners, an early stage focused enterprise VC Fund based out of Palo Alto, where he is leading investments in AI, cybersecurity, and enterprise healthcare IT. Raymond is interested in leveraging his experience as an entrepreneur, investor, and physician to help entrepreneurs build category-defining companies. Prior to his experience as a venture investor, Raymond started a KPCB-backed enterprise healthcare IT company, where he led the commercialization efforts of the technology. Raymond finished his medical training as an emergency physician at Stanford Medicine and Baylor College of Medicine, and obtained his master degree from Oxford University as a Fulbright Scholar.
Ray-Jade is the current Superintendent of Taipei Medical University, he is also a professor of surgery at Taipei Medical University. He served as the Executive Director of the Taipei Medical University Management Development Center. His research interests focus on hepatobiliary and pancreatic surgery, acute surgery, trauma epidemiology, critical care and medical information, etc. He emphasized that the global industry is undergoing a transformation. In the foreseeable future, personalized medicine is bound to become the mainstream of the healthcare industry.
Leon is an assistant professor at the University of California, San Diego, with appointments in the linguistics department and the Halıcıoğlu Data Science Institute. He was a postdoc at Stanford University and received his Ph.D. from MIT's Brain and Cognitive Sciences department. Leon uses computational modeling and experimental methods to study linguistic phenomena.
Melissa Yu aspires to advance the health and well-being of people through her products and ideas. Spurred on by personal experience, she has focused on the research and development of products that aim to fight against conditions such as liver cancer and Alzheimer's. So far, she has been a part of the international market development of two natural remedies that help combat both diseases. She was named to Forbes 30 Under 30 - Asia - Healthcare & Science 2018.
Siddarth Satish is the Founder and CEO of Gauss Surgical, a medical technology company using computer vision and machine learning to make surgery and childbirth safer and more cost-effective. Gauss’s first application, Triton, uses the iPad to monitor blood loss from digital images of sponges and canisters, with the goal of improving obstetrical safety, reducing unnecessary transfusion, and preventing retained sponges. Siddarth has led the team through seven US/EU regulatory clearances (including FDA De Novo approval and raised $40 million in venture capital). He previously served as an Entrepreneur-in-Residence at StartX, Stanford University’s Startup Accelerator, and as a SIMdesign Fellow in the Department of Surgery at Stanford. He serves on the Technology Committee of the Anesthesia Patient Safety Foundation, and was named to the Forbes 30 Under 30 list in healthcare.
Kat is co-founder and CEO of SimplyVital Health, a blockchain solution to problems in medical recordkeeping and healthcare payment systems. Fortune Magazine named her among the 34 Leaders Who Are Changing Health Care. She founded the company as a solution for problems she faced as a hospital administrator. Solutions include support for data security, care-coordination, post-hospital data, communications, and analytics for decision making and risk management. Prior to founding SimplyVital Health, Katherine was the Program Manager of the Center for Musculoskeletal Care for Yale New Haven Health. She was also a strategic planner for the medicine and surgery service lines at Yale New Haven Health and designed an enterprise wide care management dashboard at a statewide community health center network.
Disa has 15+years of experience working in technology and innovation especially in the pharmaceutical industry. In her current role as Director Head of Innovation within the Global Clinical Sciences & Operations (GCSO) group at UCB, she is responsible for evaluating, piloting, and implementing innovative solutions in clinical trials. Prior to joining the pharmaceutical industry, she was a co-founder of an IT company. She has an EMBA and B.S. in Pharmaceutical Chemistry. Disa started a cross-industry collaboration on blockchain via PhUSE where presently she is one of the co-leads. She is also a member of other blockchain consortiums. Her passion is on closing the gap for patients with unmet needs and exploring the right technologies (Blockchain, Internet of Things, Artificial Intelligence/machine learning, robotics, data discovery tools, and others) to accelerate the implementation of end-to-end patient solutions.